Exabis Library
Welcome to the e-CCO Library!
P510: Comparative effectiveness of Ustekinumab against other biologics in Inflammatory Bowel Disease: a propensity score analysis.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P510: Comparative efficacy of biologic therapies for inducing response and remission in fistulizing Crohn’s disease; Systematic Review and Network Meta-analysis
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P510: Hypergammaglobulinemia, hypoalbuminemia, and elevated CRP levels are predictors of a secondary loss of response to anti-TNFα therapy in IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P510: Infliximab in the very young: it is all about the dosing – a multi-centre study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P510: Postoperative enterocoutaneous fistula after surgery for Crohn’s disease performed in a tertiary centre over 15 years: analysis of the long-term outcomes and predictors of fistula closure
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P510: Skin anergy and latent tuberculosis in inflammatory bowel disease patients
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P511 Association of ustekinumab serum concentrations and clinical outcomes: results from the mUST-DECIDE trial
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P511: Baseline characteristics of ulcerative colitis patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (01)
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P511: Disease-specific risk factors for malnutrition development in IBD
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P511: Early prediction of steroid failure in acute severe ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P511: Efficacy of Crohn's Disease exclusion diet in different clinical scenarios in paediatrics; at onset of the disease and after loss of response to biological therapy
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P511: Evaluation of home faecal calprotectin testing to aid remote management and enhanced self-management of Inflammatory Bowel Disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P511: Radiological outcomes in perianal fistulising Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P511: Utilisation and efficacy of oral iron therapy in patients with iron deficiency anaemia in a nationwide cohort of ulcerative colitis patients
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P512 Efficacy of tofacitinib for the treatment of moderate-to-severe ulcerative colitis: real-world data
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P512: Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P512: Real world use of adalimumab: effects on corticosteroid treatment and hospital resource utilisation in UK patients with moderate/severe ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P512: Results of interim analysis of a retrospective IGIBD study on adalimumab use in real practice in Italy: the REAL-life clinical effectiveness of ADAlimumab in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P512: Safety of reduced clinical monitoring in patients with stable Inflammatory Bowel Disease on maintenance thiopurine therapy
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P512: The counts of white blood cells are not predictive for long-term remission under treatment with thiopurines: a three year Japanese multi-center retrospective cohort study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM